Clinical Research Institute of Michigan – Shores Rheumatology
Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201
- Indication: Gout
- Enrollment Status: Pre-Enrollment
- Protocol: FYU-981-CRYS-301
- Drug: Dotinurad
- Sponsor: Crystalys
- Description: A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout
